These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


203 related items for PubMed ID: 27698008

  • 1. Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients.
    Meeder AM, van der Steen MS, Rozendaal A, van Zanten AR.
    BMJ Case Rep; 2016 Oct 03; 2016():. PubMed ID: 27698008
    [Abstract] [Full Text] [Related]

  • 2. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients.
    Newman PJ, Quinn AC, Grounds RM, Hunter JM, Boyd AH, Eastwood NB, Pollard BJ, Pearson AJ, Harper NJ, Beale RJ, Sutjarittam M, Elliot JM, Bion JF.
    Crit Care Med; 1997 Jul 03; 25(7):1139-42. PubMed ID: 9233738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cisatracurium dosing in a patient with hyperthermia.
    Lim J, Cox J, Nguyen T, Arya R.
    Am J Health Syst Pharm; 2019 Jul 02; 76(14):1029-1032. PubMed ID: 31361873
    [Abstract] [Full Text] [Related]

  • 5. [The clinical pharmacology of cisatracurium].
    Mellinghoff H, Diefenbach C.
    Anaesthesist; 1997 Jun 02; 46(6):481-5. PubMed ID: 9297378
    [Abstract] [Full Text] [Related]

  • 6. [Cisatracurium--is the stereoisomer an "ideal" relaxant? Histamine liberation and tryptase determination after bolus administration of cistracurium: a comparison with vecuronium].
    Soukup J, Doenicke A, Hoernecke R, qass J.
    Anaesthesist; 1997 Jun 02; 46(6):486-91. PubMed ID: 9297379
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.
    Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ, Vender J, Howard D, Casale EJ, Murray MJ.
    Anesth Analg; 1995 Jul 02; 81(1):3-12. PubMed ID: 7598277
    [Abstract] [Full Text] [Related]

  • 8. Cisatracurium and atracurium as antigens.
    Fisher MM.
    Anaesth Intensive Care; 1999 Aug 02; 27(4):369-70. PubMed ID: 10470390
    [Abstract] [Full Text] [Related]

  • 9. Compared efficacy and tolerance of the neuromuscular blockade induced by brand-name (Nimbex®) and generic (Cisatrex®) of cisatracurium in mechanically ventilated critically ill patients: a crossover double-blind randomized study.
    Fraj N, Meddeb K, Azouzi A, Romdhani S, Saad HB, Boussarsar M.
    Pan Afr Med J; 2020 Aug 02; 37():346. PubMed ID: 33738034
    [Abstract] [Full Text] [Related]

  • 10. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L, Kramer CJ, Delcoix-Lopes S, Modrykamien AM.
    Respir Care; 2017 Jul 02; 62(7):947-952. PubMed ID: 28351905
    [Abstract] [Full Text] [Related]

  • 11. The effect of cisatracurium infusion on the energy expenditure of critically ill patients: an observational cohort study.
    Koekkoek WAC, Menger YA, van Zanten FJL, van Dijk D, van Zanten ARH.
    Crit Care; 2020 Feb 03; 24(1):32. PubMed ID: 32014039
    [Abstract] [Full Text] [Related]

  • 12. Infusion and bolus administration of cisatracurium--effects on histamine release.
    Selcuk M, Celebioglu B, Celiker V, Basgul E, Aypar U.
    Middle East J Anaesthesiol; 2005 Jun 03; 18(2):407-19. PubMed ID: 16438016
    [Abstract] [Full Text] [Related]

  • 13. [Effects of priming technique on onset profile of cisatracurium].
    Hoffmann W, Schwarz U, Ruoff M, Georgieff M, Geldner G.
    Anaesthesiol Reanim; 1999 Jun 03; 24(5):130-3. PubMed ID: 10596204
    [Abstract] [Full Text] [Related]

  • 14. [Effect of sevoflurane versus propofol-remifentanil anesthesia on neuromuscular blockade by continuous cisatracurium infusion].
    Wen LL, Lin WQ, Zhao WX, Li GC, Bai XH, Xiao JB.
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jan 03; 30(1):163-5. PubMed ID: 20118012
    [Abstract] [Full Text] [Related]

  • 15. Cisatracurium or rocuronium versus rocuronium-cisatracurium combination.
    Zeidan A, Nahle N, Maaliki H, Baraka A.
    Middle East J Anaesthesiol; 2006 Jun 03; 18(5):879-86. PubMed ID: 17094524
    [Abstract] [Full Text] [Related]

  • 16. Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
    Trissel LA, Martinez JF, Gilbert DL.
    Am J Health Syst Pharm; 1997 Aug 01; 54(15):1735-41. PubMed ID: 9262747
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anaphylactoid reactions after cisatracurium administration in six patients.
    Krombach J, Hunzelmann N, Köster F, Bischoff A, Hoffmann-Menzel H, Buzello W.
    Anesth Analg; 2001 Nov 01; 93(5):1257-9, table of contents. PubMed ID: 11682408
    [Abstract] [Full Text] [Related]

  • 20. Delayed recovery of limb muscle power after general anesthesia with cisatracurium in a dermatomyositis patient.
    You AH, Kang HY, Park SW, Kim Y.
    J Clin Anesth; 2018 Nov 01; 50():59-60. PubMed ID: 29980001
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.